Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.39 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.39 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.39 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.39 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.39 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.39 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 3/20 | 0.39 |
| ▸ | DRD3 | P35462 | 3/20 | 0.39 |
| ▸ | LPL | P06858 | 2/20 | 0.39 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.39 |
| ▸ | DRD1 | P21728 | 2/20 | 0.39 |
| ▸ | DRD4 | P21917 | 2/20 | 0.39 |
| ▸ | DRD5 | P21918 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL380954 | 0.88 | CNR1 (0.50) | CNR1CNR2MEN1KMT2AKIF11 | |
| SCHEMBL7648656 | 0.87 | LPL (0.44) | CNR1CNR2MEN1KMT2AKIF11 | |
| SCHEMBL8461002 | 0.87 | LPL (0.49) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL8860787 | 0.86 | TP53 (0.44) | MEN1KMT2AKIF11SIGMAR1TAAR1 | |
| SCHEMBL2920784 | 0.86 | GRIN2D (0.42) | CNR1CNR2MEN1KMT2AKIF11 | |
| SCHEMBL28140452 | 0.85 | LPL (0.56) | LPLLIPG | |
| SCHEMBL5252816 | 0.85 | LPL (0.47) | CNR1CNR2LPLLIPG | |
| SCHEMBL7648644 | 0.84 | LPL (0.49) | SIGMAR1LPLLIPG | |
| SCHEMBL5424543 | 0.81 | MTNR1A (0.47) | CNR1CNR2MEN1KMT2AKIF11 | |
| SCHEMBL589019 | 0.81 | TP53 (0.48) | CNR1CNR2MEN1KMT2AKIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 253 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12037439-B2 | Water-based polymer hydrogel system | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2024-07-16 | — | — | US | disclosed |
| US-20240216872-A1 | CROSSFLOW DESALINATION DEVICE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-07-04 | — | — | US | disclosed |
| WO-2024118068-A1 | INKJET INKS CONTAINING AMINE MODIFIED SILICONE | KAO CORPORATION (JP) | 2024-06-06 | — | — | WO | disclosed |
| WO-2024118619-A1 | INKJET INKS CONTAINING AMINE MODIFIED SILICONE | KAO CORPORATION (JP) | 2024-06-06 | — | — | WO | disclosed |
| US-11981690-B2 | Alkyl-terminated thiocarbamate complex and method for treating cancer | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-05-14 | — | — | US | disclosed |
| US-11969696-B2 | Multi-layer membrane containing mixed polyamide selective layer and methods of making thereof | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-04-30 | — | — | US | disclosed |
| US-11958867-B2 | Alkyl amine dithiocarbamate gold complex for cancer treatment | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-04-16 | — | — | US | disclosed |
| US-20240076513-A1 | SOLVENT-BASED INKJET INKS | KAO CORPORATION (JP) | 2024-03-07 | — | — | US | disclosed |
| CN-116390815-B | Inkjet inks suitable for printing on non-porous substrates | 花王株式会社 | 2024-02-13 | — | — | CN | disclosed |
| US-11897789-B2 | Polymer/carbon nanotube composite and methods for wastewater treatment | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-02-13 | — | — | US | disclosed |
| EP-1229014-A1 | Purification process for arylcarboxylic acids | ALBEMARLE CORPORATION (US) | 2002-08-07 | — | — | EP | disclosed |
| EP-1095005-A1 | PREPARATION OF CARBOXYLIC COMPOUNDS AND THEIR DERIVATIVES | ALBEMARLE CORPORATION (US) | 2001-05-02 | — | — | EP | disclosed |
| EP-1067130-A1 | TRIAZOLO DERIVATIVES AND CHEMOKINE INHIBITORS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | TORAY INDUSTRIES, INC. (JP) | 2001-01-10 | — | — | EP | disclosed |
| US-6096920-A | LARGE-SCALE PRODUCTION OF CERTAIN AROMATICALLY-SUBSTITUTED ALIPHATIC CARBOXYLIC ACIDS AND THEIR ACID DERIVATIVES | ALBEMARLE CORPORATION (US) | 2000-08-01 | — | — | US | disclosed |
| US-6080888-A | REACTING ARYL HALIDE WITH AN OLEFINIC COMPOUND IN THE PRESENCE OF A POLAR LIQUID REACTION MEDIUM CONTAINING A SECONDARY OR TERTIARY AMINE AS A HYDROGEN HALIDE ACCEPTOR, A CATALYST SYSTEM FORMED FROM PALLADIUM, A PHOSPHINE | ALBEMARLE CORPORATION (US) | 2000-06-27 | — | — | US | disclosed |
| WO-2000002840-A1 | PREPARATION OF CARBOXYLIC COMPOUNDS AND THEIR DERIVATIVES | ALBEMARLE CORPORATION (US) | 2000-01-20 | — | — | WO | disclosed |
| EP-0961763-A1 | PREPARATION OF OLEFINIC COMPOUNDS AND CARBOXYLIC DERIVATIVES THEREOF | ALBEMARLE CORPORATION (US) | 1999-12-08 | — | — | EP | disclosed |
| EP-0961765-A2 | PREPARATION OF CARBOXYLIC COMPOUNDS AND THEIR DERIVATIVES | ALBEMARLE CORPORATION (US) | 1999-12-08 | — | — | EP | disclosed |
| WO-1998030522-A1 | PREPARATION OF OLEFINIC COMPOUNDS AND CARBOXYLIC DERIVATIVES THEREOF | ALBEMARLE CORPORATION (US) | 1998-07-16 | — | — | WO | disclosed |
| WO-1998030529-A2 | PREPARATION OF CARBOXYLIC COMPOUNDS AND THEIR DERIVATIVES | ALBEMARLE CORPORATION (US) | 1998-07-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11958867-B2 | Alkyl amine dithiocarbamate gold complex for cancer treatment | IDH3B, HCCS, IDH3A | CNR1 284/4885CNR2 645/4885MEN1 1422/4885 |
| US-11981690-B2 | Alkyl-terminated thiocarbamate complex and method for treating cancer | HCCS, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, IDH3B | CNR1 136/4885CNR2 277/4885MEN1 1295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.